European journal of medicinal chemistry

Scientific reports

PloS one

Antimicrobial agents and chemotherapy

The Journal of organic chemistry

Bioorganic & medicinal chemistry letters

Journal of medicinal chemistry

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Frontiers in medicine

The Journal of biological chemistry

Frontiers in microbiology

BMC infectious diseases

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Biomacromolecules

Journal of pharmaceutical and biomedical analysis

medicinal chemistry (shariqah (united arab emirates))

Journal of global antimicrobial resistance

Nature

eskişehir türk dünyası uygulama ve araştırma merkezi halk sağlığı dergisi

case reports in infectious diseases

BMC genomics

biochimie

emerging microbes & infections

forensic science, medicine, and pathology

the lancet infectious diseases

journal of infection in developing countries

current cardiology reports

new microbes and new infections

medical sciences (basel, switzerland)

tuberculosis (edinburgh, scotland)

international journal of antimicrobial agents

xi bao yu fen zi mian yi xue za zhi = chinese journal of cellular and molecular immunology

Revista da Associacao Medica Brasileira (1992)

Annual Review of Biochemistry

cell chemical biology

journal of chemotherapy (florence, italy)

medical mycology case reports

Protein science : a publication of the Protein Society

international journal of medical microbiology : ijmm

reports of biochemistry & molecular biology

[1] Transposon libraries identify novel Mycobacterium bovis BCG genes involved in the dynamic interactions required for BCG to persist during in vivo passage in cattle.

[2] Glycopolycation-DNA Polyplex Formulation N/P Ratio Affects Stability, Hemocompatibility, and in Vivo Biodistribution.

[3] Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach.

[4] Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).

[5] Resolving a clinical tuberculosis outbreak using palaeogenomic genome reconstruction methodologies.

[6] Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.

[7] Structural characterization of glycinamide-RNase-transformylase T from .

[8] Structural analysis of mycobacterial homoserine transacetylases central to methionine biosynthesis reveals druggable active site.

[9] Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal.

[10] Structural Insights into Phosphopantetheinyl Hydrolase PptH from Mycobacterium tuberculosis.

[11] Early Diagnosis of Latent Tuberculosis Reactivation due to Drug Interaction between Cobicistat and Intranasal Fluticasone.

[12] Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases.

[13] Genotyping of Mycobacterium tuberculosis spreading in Hanoi, Vietnam using conventional and whole genome sequencing methods.

[14] Reduced transmission of Mycobacterium africanum compared to Mycobacterium tuberculosis in urban West Africa.

[15] Deciphering the essentiality and function of SxSx motif in Mycobacterium tuberculosis UvrB.

[16] Diagnosis and Management of Tuberculous Pericarditis: What Is New?

[17] HIV-related nephropathy: new aspects of an old paradigm.

[18] Resistance Sniffer: An online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data.

[19] Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: A simulated client method.

[20] Microscopic Observation Drug Susceptibility (MODS) Assay: A Convenient Method for Determining Antibiogram of Clinical Isolates of in Ghana.

[21] Whole genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.

[22] Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.

[23] The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey.

[24] Predominance of Central Asian strain (ST 26) in Mycobacterium tuberculosis isolates from Balochistan by spoligotyping.

[25] A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA.

[26] Evaluating Enhancer Function and Transcription.

[27] The Introduction of Hydrazone, Hydrazide or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against M. tuberculosis.

[28] Cloning, Expression and Purification of Espc, Espb and Espc/Espb Proteins of ESX-1 Secretion System.

[29] Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating Mycobacterium tuberculosis Infections

[30] The Role of Dendritic Cells in TB and HIV Infection

[31] tuberculosis in children from diagnosis to decision to treat

[32] a novel approach for amplification and purification of mouse oligodendrocyte progenitor cells

[33] glutamine synthetase drugability beyond its active site: exploring oligomerization interfaces and pockets

[34] diagnóstico molecular de tuberculosis extrapulmonar y sensibilidad a rifampicina con un método automatizado en tiempo real

[35] detection of ofloxacin resistance by nitrate reductase assay in mycobacterium tuberculosis isolates from extrapulmonary tuberculosis

[36] antibacterial activity of medicinal aqueous plant extracts against mycobacterium tuberculosis

[37] diagnostic value of mycobacteriophage based fast plaque technique for early detection of pulmonary tuberculosis

[38] a case report of vascular catheter-associated bacteremia caused by mycobacterium tuberculosis in a non-immunosuppressed patient

[39] relative value of immunohistochemistry in detection of mycobacterial antigen in suspected cases of tuberculosis in tissue sections

[40] a study of unusual pacemaker infection by mycobacterium tuberculosis in indian patients

[41] importance of the α10 helix for devr activation: a road map for screening inhibitors against devr-mediated dormancy of mycobacterium tuberculosis

[42] mutations in the rpob gene of rifampicin-resistant mycobacterium tuberculosis strains isolated in brazil and france

[43] influence of stress and antibiotic resistance on cell-length distribution in mycobacterium tuberculosis clinical isolates

[44] specific and cross-reactive immune response against mycobacterium tuberculosis antigens in mice immunized with proteoliposomes from mycobacterium bovis bcg

[45] a rapid growth-independent antibiotic resistance detection test by sybr green/propidium iodide viability assay

[46] the cording phenotype of mycobacterium tuberculosis induces the formation of extracellular traps in human macrophages

[47] disseminated tuberculosis with prostatic abscesses in an immunocompromised patient—a case report and review of literature

[48] protein turnover in mycobacterial proteomics

[49] can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

[50] comparative proteomic analysis of mycobacterium tuberculosis lineage 7 and lineage 4 strains reveals differentially abundant proteins linked to slow growth and virulence

[51] pko: alternative method for isolating mycobacteria from sputum pko: um método alternativo para o isolamento de micobactérias em amostras de escarro

[52] falso diagnóstico de tuberculosis por cultivo false diagnosis of tuberculosis by culture

[53] comunicantes domiciliares jovens de pacientes com tb pulmonar na região da grande vitória (es): um estudo de coorte juvenile household contacts aged 15 or younger of patients with pulmonary tb in the greater metropolitan area of vitória, brazil: a cohort study

[54] strategies to improve vaccine efficacy against tuberculosis by targeting innate immunity

[55] high diversity of multidrug-resistant mycobacterium tuberculosis central asian strain isolates in nepal

[56] vaccines for leprosy and tuberculosis: opportunities for shared research, development, and application

[57] molecular cloning, expression and purification of protein tb10.4 secreted by mycobacterium tuberculosis

[58] evaluation of possible occurrence of mutation in mmr repair system genes in resistant and sensitiveclinical strains of mycobacterium tuberculosisby using sequencing method

[59] memory of natural killer cells: a new chance against mycobacterium tuberculosis?

[60] the role of transport mechanisms in mycobacterium tuberculosis drug resistance and tolerance

[61] pe11 (rv1169c) selectively altering fatty acid components of mycobacterium smegmatis and host interleukin-6 level accompany with cell death

[62] mycobacterium tuberculosis infection and innate responses in a new model of lung alveolar macrophages

[63] building a better bacillus: the emergence of mycobacterium tuberculosis

[64] insufficient generation of mycobactericidal mediators and inadequate level of phagosomal maturation are related with susceptibility to virulent mycobacterium tuberculosis infection in mouse macrophages

[65] extracellular sphingomyelinase rv0888 of mycobacterium tuberculosis contributes to pathological lung injury of mycobacterium smegmatis in mice via inducing formation of neutrophil extracellular traps

[66] the response of mycobacterium tuberculosis to reactive oxygen and nitrogen species

[67] comparison of pyrazinamide drug susceptibility of <i>m.tuberculosis</i> by radiometric bactec and enzymatic pyrazinamidase assay

[68] disrupted human-pathogen co-evolution: a model for disease

[69] comparative genomics of a bovine mycobacterium tuberculosis isolate and other strains reveals its potential mechanism of bovine adaptation

[70] high levels of anti-tuberculin (igg) antibodies correlate with the blocking of t-cell proliferation in individuals with high exposure to mycobacterium tuberculosis

[71] To fight tuberculosis, fund basic research

[72] Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study

[73] A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen).

[74] Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease.

[75] One-Pot Transformation of Hypervalent Iodines into Diversified Phenoxazine Analogues as Promising Photocatalysts.

[76] Evaluation of genetic mutations associated with phenotypic resistance to Fluoroquinolones, Bedaquiline, and Linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis.

[77] Hit or miss - A metagenomic evaluation of intra-bone variability of host pathogen load in tuberculosis-infected human remains.

[78] The crystal structure of AcrR from Mycobacterium tuberculosis reveals a one-component transcriptional regulation mechanism.

[79] Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains

[80] AKCİĞER TÜBERKÜLOZLU OLGULARDAN İZOLE EDİLEN MYCOBACTERİUM TUBERCULOSİS İZOLATLARINDA PRİMER TÜBERKÜLOZ İLAÇ DİRENCİNİN ARAŞTIRILMASI

[81] Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China

[82] Spoligotyping analysis of Mycobacterium tuberculosis in Khyber Pakhtunkhwa area, Pakistan

[83] Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis

[84] Characterization of the most common embCAB gene mutations associated with ethambutol resistance in Mycobacterium tuberculosis isolates from Iran

[85] Drug-resistance profiling and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Saudi Arabia revealed by whole genome sequencing

[86] Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis

[87] Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China

[88] Genetic characterization of Mycobacterium tuberculosis complex isolates circulating in Abuja, Nigeria

[89] Phenotypic and genotypic drug sensitivity of Mycobacterium tuberculosis complex isolated from South Omo Zone, Southern Ethiopia

[90] Mutation EthAW21R confers co-resistance to protionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv

[91] Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test&nbsp;Mycobacterium tuberculosis specimens from Bangladesh

[92] Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones

[93] Viability, biofilm formation, and MazEF expression in drug-sensitive and drug-resistant Mycobacterium tuberculosis strains circulating in Xinjiang, China

[94] Clustering and recent transmission of Mycobacterium tuberculosis in a Chinese population

[95] Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis [Corrigendum]

[96] Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis

[97] Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia

[98] Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis

[99] Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco

[100] AKCİĞER TÜBERKÜLOZLU OLGULARDAN İZOLE EDİLEN MYCOBACTERİUM TUBERCULOSİS İZOLATLARINDA PRİMER TÜBERKÜLOZ İLAÇ DİRENCİNİN ARAŞTIRILMASI

[101] Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China